shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > Entertainment News > Hollywood News > Article > Demi Lovato may be suffering from overdose complication

Demi Lovato may be suffering from overdose complication

Updated on: 31 July,2018 03:16 PM IST  |  Los Angeles
IANS |

On July 25, Demi Lovato was found unconscious following an overdose. She was reportedly treated with Narcan, a medication designed to rapidly reverse opioid overdose

Demi Lovato may be suffering from overdose complication

Demi Lovato

Singer Demi Lovato is still hospitalised here six days after a suspected drug overdose and is reportedly suffering from complications.


The Tell me you love me singer is reportedly suffering complications from the overdose, including extreme nausea and a high fever, reports tmz.com.


While doctors have not decided when Lovato can be released from the hospital, "she is under the care of medical experts and is expected to make a full recovery", a source said.


On July 25, Lovato was found unconscious following an overdose. She was reportedly treated with Narcan, a medication designed to rapidly reverse opioid overdose, before being rushed to the hospital.

Catch up on all the latest entertainment news and gossip here. Also download the new mid-day Android and iOS apps to get latest updates

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK